Skip to main content

Table 4 Thresholds of LOARs for G4 lymphopenia

From: Characterization and dosimetric predictors for absolute lymphocyte count changes during neoadjuvant chemoradiotherapy with or without pembrolizumab for esophageal squamous cell carcinoma: an analysis of a prospective cohort

Variables

AUC

Optimal cut-off value

TVB

  

 V5

0.703

80.7%

 V10

0.674

76.87%

 V20

0.602

69.54%

Mean TVB dose

0.654

19.04 Gy

Mean Cardiopulmonary Dose

0.696

11.10 Gy

Mean Whole Body Dose

0.642

3.07 Gy

Mean ribs dose

0.662

8.27 Gy

Mean spleen dose

0.747

4.31 Gy

 V5

0.736

0.37%

 V10

0.716

2.26%

 V20

0.703

0.015%

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us